Lidia Robert Selected Research

SCH772984

1/2018	Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.
8/2014	Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lidia Robert Research Topics

Disease

16	Melanoma (Melanoma, Malignant) 01/2019 - 04/2014
11	Neoplasms (Cancer) 01/2019 - 04/2014
1	Inflammation (Inflammations) 01/2018
1	Colonic Neoplasms (Colon Cancer) 10/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015
1	Lymphoma (Lymphomas) 06/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 06/2015

Drug/Important Bio-Agent (IBA)

3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2017 - 07/2014
3	LigandsIBA 06/2015 - 07/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 11/2014
2	SCH772984IBA 01/2018 - 08/2014
2	pembrolizumabIBA 06/2015 - 11/2014
2	dabrafenibIBA 03/2015 - 04/2014
2	AntigensIBA 03/2015 - 11/2014
1	PlasticsIBA 01/2019
1	IronIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	MART-1 AntigenIBA 01/2018
1	MK-8353IBA 01/2018
1	AMG 337IBA 03/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2017
1	Programmed Cell Death 1 ReceptorIBA 10/2016
1	CarcinogensIBA 10/2016
1	AntibodiesIBA 06/2015
1	B7-H1 AntigenIBA 06/2015
1	NivolumabIBA 06/2015
1	pidilizumabIBA 06/2015
1	trametinibIBA 03/2015
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	Transcription Factors (Transcription Factor)IBA 02/2015
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2015
1	ProteomeIBA 02/2015
1	Microphthalmia-Associated Transcription FactorIBA 12/2014
1	VemurafenibIBA 08/2014
1	Adenosine Triphosphate (ATP)IBA 04/2014

Therapy/Procedure

14	Therapeutics 01/2019 - 04/2014
5	Immunotherapy 01/2018 - 07/2014
1	Ligation 11/2014